Title : Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer.

Pub. Date : 2021

PMID : 34803493






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Results: We found that upregulation of the LPL/FABP4/CPT1 molecular axis, as a fatty acid metabolic reprogramming process, occurred specifically during the NASH phase. Fatty Acids fatty acid binding protein 4, adipocyte Mus musculus